Results 191 to 200 of about 84,630 (262)

Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes. [PDF]

BMJ Open Diabetes Res Care
Kishimori T, Kato T, Wada A, Tani A, Yamaji R, Koike J, Iwasaki Y, Matsumoto T, Yagi T, Okada M.   +9 more
europepmc   +1 more source

Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series. [PDF]

Calcif Tissue Int
Turan I, Atar M, Eltan M, Anik A, Bitkin EC, Dilek SO, Cay M, Bozdogan ST, Döneray H, Kotan D, Turan S, Yüksel B, Topaloglu AK.   +12 more
europepmc   +1 more source

Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: A Case Series and Clinical Reflections. [PDF]

Cureus
Sultan A, Naeem MN, Javed N, Rehman M, Danial A.   +4 more
europepmc   +1 more source

A Comparative Analysis of Diabetic Ketoacidosis (DKA) in Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Users Versus Non-users: A Systematic Review. [PDF]

Cureus
Abdella Altom SA, Alhajri AHM, Ali HKM, Mohammed Ahmed DA, Rabah Rahma MA, Mohamed Ahmed TA, Mohmmed Abd Alatif MM, Hassan Ahmed RA.   +7 more
europepmc   +1 more source

Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice

, 2014
Naoto Terami, Daisuke Ogawa, Hiromi Tachibana, Takashi Hatanaka, Jun Wada, Atsuko Nakatsuka, Jun Eguchi, Chikage Sato Horiguchi, Naoko Nishii, Hiroshi Yamada, Kohji Takei, Hirofumi Makino   +11 more
openalex   +2 more sources

Elevated carbon dioxide upregulates NBCn1 Na⁺/HCO₃⁻cotransporter in human embryonic kidney cells

, 2013
Alejandro Orlowski, Lorena A. Vargas, Ernesto A. Aiello, Bernardo V. Álvarez   +3 more
openalex   +2 more sources

Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis. [PDF]

Clin Mol Hepatol
Choi J, Fulop D, Nguyen VH, Przybyszewski E, Song J, Carroll A, Michta M, Almazan E, Simon TG, Chung RT.   +9 more
europepmc   +1 more source

Increased HbA1c relative to actual glycemic control in patients treated with sodium-glucose cotransporter 2 inhibitors. [PDF]

J Diabetes Investig
Mizutani K, Uenishi E, Onoue T, Maeda R, Suzuki K, Handa T, Kobayashi T, Iwama S, Miyata T, Sugiyama M, Hagiwara D, Suga H, Okazaki M, Hashizume A, Arima H.   +14 more
europepmc   +1 more source

Na-Cl Cotransporter (SLC12A3) Inhibition Exacerbates Age-Related Macular Degeneration Via the Nrf2/HO-1 Ferroptosis Pathway [PDF]

Chengming Chen, Tingke Xie, Huan Zhang, Lifu Chang, Yanyan Lan, Chao Fan, Dongyu Wei, Xiaolan Wang, Sida Liu, Yixuan Chen, Yuhao Chen, Xuejiao Wang, Xiaolong Yan, Lei Shang, Liyuan Tao, Jing Han   +15 more
openalex   +1 more source